Case number 1:19-cv-00351
Galderma Laboratories, L.P. et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (10) |
| Mar 16, 2020 | 99 | Patent/Trademark Report to Commissioner (1) |
| Mar 16, 2020 | 99 | Order (2) |
| Mar 16, 2020 | 99 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,206,939 B2. (Attachments: # (1) Order)(nms) |
| Mar 12, 2020 | 98 | Order (2) Docket Text: SO ORDERED Granting [97] Stipulation and Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 3/12/2020. (nms) |
| Mar 11, 2020 | 97 | Stipulation of Dismissal (2) Docket Text: STIPULATION and Order Dismissing Case, by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) Modified on 3/12/2020 (nms). |
| Mar 6, 2020 | 96 | Redacted Document (3) Docket Text: REDACTED VERSION of [95] Stipulation, by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Lyons, Jeffrey) Modified on 3/12/2020 (nms). |
| Mar 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Granting (95 in 19-cv-351-RGA; 15 in 19-mc-347-RGA) Sealed Stipulation and Order to Stay. Signed by Judge Richard G. Andrews on 3/2/2020. Associated Cases: 1:19-cv-00351-RGA, 1:19-mc-00347-RGA(nms) |
| Feb 13, 2020 | 93 | Redacted Document (4) |
| Feb 13, 2020 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[85]. (nms) |
| Feb 13, 2020 | 93 | Exhibit 1-9 (75) |
| Feb 13, 2020 | 94 | Redacted Document (2) Docket Text: REDACTED VERSION of [89] Letter by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Feb 13, 2020 | 93 | Main Document (4) Docket Text: REDACTED VERSION of [85] Letter by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Attachments: # (1) Exhibit 1-9)(Tigan, Jeremy) |
| Feb 12, 2020 | 91 | Redacted Document (5) |
| Feb 12, 2020 | 92 | Redacted Document (3) |
| Feb 12, 2020 | 91 | Exhibits 1-18 (114) |
| Feb 12, 2020 | 92 | Exhibits 1-2 (30) |
| Feb 12, 2020 | 91 | Main Document (5) Docket Text: REDACTED VERSION of [86] Letter,, by Teva Pharmaceuticals USA, Inc.. (Attachments: # (1) Exhibits 1-18)(Keller, Karen) |
| Feb 12, 2020 | 92 | Main Document (3) Docket Text: REDACTED VERSION of [88] Letter by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Attachments: # (1) Exhibits 1-2)(Lyons, Jeffrey) |
| Feb 11, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Discovery Conference scheduled for 2/12/2020, is CANCELLED. Ordered by Judge Richard G. Andrews on 2/11/2020. (nms) |
| Feb 5, 2020 | 87 | Letter (2) Docket Text: Letter to The Honorable Richard Andrews, from Nathan R. Hoeschen, in response to Letter (D.I. [85]). (Hoeschen, Nathan) Modified on 2/6/2020 (nms). |
| Jan 30, 2020 | 84 | Memorandum and Order (3) Docket Text: MEMORANDUM ORDER: The Motion for Leave to File First Amended Complaint (D.I. [67]) is DENIED. Signed by Judge Richard G. Andrews on 1/30/2020. (nms) |
| Jan 27, 2020 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Supplemental Responses and Objections to Plaintiffs Second Set of Interrogatories (Nos. 5-7) to Defendant Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 27, 2020 | 83 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel Justin Bova by Teva Pharmaceuticals USA, Inc. (Keller, Karen) |
| Jan 23, 2020 | 81 | Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument, by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 1/24/2020 (nms). |
| Jan 21, 2020 | 77 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jerome Brathwaite on a date agreed upon by the parties and deponent filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 21, 2020 | 78 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Matt Gambino on a date agreed upon by the parties and deponent filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 21, 2020 | 79 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Vincent Manetta on a date agreed upon by the parties and deponent filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 21, 2020 | 80 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sandrine Segura on a date agreed upon by the parties and deponent filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 17, 2020 | N/A | Oral Order (0) |
| Jan 16, 2020 | 75 | Reply Brief (6) Docket Text: REPLY BRIEF re [67] MOTION for Leave to File First Amended Complaint for Patent Infringement filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) |
| Jan 9, 2020 | 74 | Redacted Document (30) Docket Text: REDACTED VERSION of [69] Answering Brief in Opposition, by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Jan 7, 2020 | N/A | SO ORDERED (0) |
| Jan 7, 2020 | 73 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to file a reply brief in support of their Motion for Leave to File First Amended Complaint for Patent Infringement (D.I. 67) to January 16, 2020 - filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) |
| Jan 2, 2020 | N/A | Redaction Notice (0) |
| Jan 2, 2020 | 70 | Redacted Document (30) Docket Text: REDACTED VERSION of [67] MOTION for Leave to File First Amended Complaint for Patent Infringement by Galderma Laboratories, L.P., Galderma S.A.. (Tigan, Jeremy) |
| Jan 2, 2020 | 71 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Michael Graeber filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 2, 2020 | 72 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jean Jacovella filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Dec 19, 2019 | 68 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Responses and Objections to Plaintiffs' Second Set of Requests for Production (Nos. 8-36) to Defendant Teva Pharmaceuticals USA, Inc. (2) Defendant's Responses and Objections to Plaintiffs' Second Set of Interrogatories (5-8) to Defendant Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Dec 18, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The brief filed at D.I. 66 has been removed from the docket. The motion that the brief related to was filed in another matter. (nms) |
| Dec 18, 2019 | N/A | Set Answering Brief Deadline (0) Docket Text: Set Answering Brief Deadline re [67] MOTION for Leave to File First Amended Complaint for Patent Infringement. Answering Brief/Response due date per Local Rules is 1/2/2020. (nms) |
| Dec 18, 2019 | 66 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Galderma's Responses and Objections to Teva's Second Set of Interrogatories (Nos. 7-14) filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Dec 16, 2019 | 65 | Jury Demand (3) Docket Text: DEMAND for Trial by Jury by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) |
| Dec 11, 2019 | 64 | Order (3) Docket Text: ORDER re [62] Stipulation and Proposed Order to Amend Schedule (*Reset Deadlines/Hearings: Dispositive Motions due by 10/8/2020, A Jury Trial is set for 2/22/2021, at 9:30 AM, A Pretrial Conference is set for 2/5/2021, at 8:30 AM in Courtroom 6A). The Court is signing the order without ruling that a jury trial is appropriate in this case or agreeing that the trial should be scheduled for five days. Signed by Judge Richard G. Andrews on 12/10/2019. (nms) |
| Dec 10, 2019 | 62 | Stipulation (3) Docket Text: STIPULATION to Amend Schedule by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) |
| Dec 10, 2019 | 63 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Galderma's Responses and Objections to Teva's Second Set of Requests for Production of Documents (Nos. 29-63) and (2) Galderma's Responses and Objections to Teva's Third Set of Requests for Production of Documents (Nos. 64-68) filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Dec 9, 2019 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Defense counsel to initiate the call. A Telephone Conference is set for 2/3/2020 at 10:00 AM Eastern Time with Judge Mary Pat Thynge. Ordered by Judge Mary Pat Thynge on 12/9/19. Associated Cases: 1:19-cv-00351-RGA, 1:17-cv-01783-RGA(cak) |
| Dec 4, 2019 | N/A | CORRECTING ENTRY: (0) |
| Nov 25, 2019 | N/A | Order Setting Teleconference (0) |
| Nov 19, 2019 | 59 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Teva's Subpoenas to Weihong Hsing, Ph.D., Sara E. Sims, Ph.D. and Panitch Schwarze Belisario & Nadel LLP filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Nov 13, 2019 | 54 | Disclosure Statement (3) Docket Text: Second Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent EQT VIII SCSp, Corporate Parent EQT VIII Co-Investment (D) SCSp, Corporate Parent Sunshine Luxembourg II S.a.r.l. for Nestle Skin Health S.A.; Corporate Parent Galderma General LLC, Corporate Parent Galderma Limited LLC for Galderma Laboratories, L.P.; Corporate Parent Galderma Pharma S.A. for Galderma S.A. filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) Modified on 11/14/2019 (nms). |
| Nov 13, 2019 | 55 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Steve Midgley on December 8, 2019 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 13, 2019 | 56 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jessica Mikus on December 8, 2019 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 13, 2019 | 57 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Eric Terranova on December 8, 2019 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 13, 2019 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Initial Disclosure of Invalidity Contentions Pursuant to Section 4(d) of the District of Delawares Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Nov 8, 2019 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants Responses and Objections to Plaintiffs First Set of Requests forProduction (Nos. 1-7) to Defendant Teva Pharmaceuticals USA, Inc. 2) Defendants Responses and Objections to Plaintiffs First Set of Interrogatories(1-4) to Defendants Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Nov 8, 2019 | 50 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Bryan Bart on December 2, 2019 filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Nov 8, 2019 | 51 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on Mutually Agreeable Date filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Nov 8, 2019 | 52 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Galderma's Responses and Objections to Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Requests for Production of Documents (Nos. 1-28), (2) Galderma's Responses and Objections to Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Interrogatories (Nos. 1-6), (3) Plaintiffs' Second Set of Requests for Production to Defendant Teva Pharmaceuticals USA, Inc., (4) Plaintiffs' Second Set of Interrogatories to Defendant Teva Pharmaceuticals USA, Inc., and (5) Plaintiffs' Rule 26(a)(1) First Amended Initial Disclosures filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Nov 8, 2019 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Subpoena for deposition testimony and duces tecum of Panitch Schwarze Belisario & Nadel, LLP., 2. Subpoena for deposition testimony and the production of documents and things of Sara E. Sims, Ph.D., and 3. Subpoena for deposition testimony and the production of documents and things of Weihong Hsing, Ph.D. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Nov 6, 2019 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Third Set of Requests for the Production of Documents (Nos. 64-68) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Nov 5, 2019 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Second Set of Requests for the Production of Documents (Nos. 29-63) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Nov 4, 2019 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Second Set of Interrogatories (Nos. 7-14) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 29, 2019 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva Pharmaceuticals USA, Inc.'s Notice of Deposition of Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 28, 2019 | 44 | Order (2) Docket Text: CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 10/28/2019. (nms) |
| Oct 23, 2019 | 41 | Memorandum Opinion (6) Docket Text: MEMORANDUM OPINION providing claim construction of a term in U.S. Patent No. 10,206,939. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion suitable for submission to the jury. Signed by Judge Richard G. Andrews on 10/22/2019. (nms) |
| Oct 23, 2019 | N/A | Oral Order (0) |
| Oct 23, 2019 | 43 | Proposed Order (2) Docket Text: PROPOSED Claim Construction Order, by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) Modified on 10/24/2019 (nms). |
| Oct 22, 2019 | N/A | SO ORDERED (0) |
| Oct 22, 2019 | 40 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jamil N. Alibhai - filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) |
| Oct 21, 2019 | N/A | SO ORDERED (0) |
| Oct 21, 2019 | 38 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kelly P. Chen - filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) |
| Oct 21, 2019 | 39 | Order Setting Mediation Conferences (6) Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 12/9/2019 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/21/19. Associated Cases: 1:17-cv-01783-RGA, 1:19-cv-00351-RGA(cak) |
| Oct 15, 2019 | N/A | Oral Order (0) |
| Oct 11, 2019 | 36 | Claim Construction Opening Brief (19) |
| Oct 11, 2019 | 36 | Exhibit 1-7 (25) |
| Oct 11, 2019 | 36 | Main Document (19) Docket Text: Joint Claim Construction Brief, filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Attachments: # (1) Exhibits 1-7)(Tigan, Jeremy) Modified on 10/11/2019 (nms). |
| Oct 9, 2019 | 35 | Disclosure Statement (3) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent EQT VIII SCSp, Corporate Parent EQT VIII Co-Investment (D) SCSp, Corporate Parent Sunshine Luxembourg II S.a.r.l. for Nestle Skin Health S.A.; Corporate Parent Galderma General LLC, Corporate Parent Galderma Limited LLC for Galderma Laboratories, L.P.; Corporate Parent Galderma Pharma S.A. for Galderma S.A. filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) |
| Oct 7, 2019 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Sur-Reply Claim Construction Brief filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 30, 2019 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Interrogatories (Nos. 1-6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Sep 30, 2019 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions Pursuant to Section 4(c) of the District of Delaware's Default Standard for Discovery of Electronically Stored Information filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Sep 27, 2019 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's First Set of Requests for the Production of Documents (Nos. 1-28) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 26, 2019 | 30 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Sep 24, 2019 | 29 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendant Teva Pharmaceuticals USA, Inc. and (2) Plaintiffs' First Set of Requests for Production to Defendant Teva Pharmaceuticals USA, Inc. filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Sep 13, 2019 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Responsive Claim Construction Brief filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Aug 22, 2019 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Aug 9, 2019 | 26 | Order (19) Docket Text: SO ORDERED Granting [24] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/8/2019. (nms) |
| Aug 8, 2019 | 24 | Proposed Order (19) Docket Text: PROPOSED Stipulated Protective Order, by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) Modified on 8/8/2019 (nms). |
| Aug 8, 2019 | 25 | Claim Construction Chart (5) |
| Aug 8, 2019 | 25 | Exhibit A-B (45) |
| Aug 8, 2019 | 25 | Main Document (5) Docket Text: Joint Claim Construction Chart, by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Attachments: # (1) Exhibits A-B)(Tigan, Jeremy) Modified on 8/8/2019 (nms). |
| Aug 1, 2019 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Under Paragraphs 3 and 4 of the District of Delaware Default Standard for Discovery filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Jul 31, 2019 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Disclosures Under Paragraph 3 of The District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 25, 2019 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Claim Construction Issue Identification of Defendant Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Thomas F. Fleming, Ashley Ross for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 16, 2019 | N/A | Order Setting Teleconference (0) |
| Jul 10, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jul 9, 2019 | 18 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 8/6/2019 at 9:30 AM Eastern Time before Judge Mary Pat Thynge. Signed by Judge Mary Pat Thynge on 7/9/19. (cak) |
| Jul 9, 2019 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Rule 26(a)(1) Initial Disclosures filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jul 8, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Jul 8, 2019 | 16 | Transcript (7) Docket Text: Official Transcript of Scheduling Conference held on 07/01/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/29/2019. Redacted Transcript Deadline set for 8/8/2019. Release of Transcript Restriction set for 10/7/2019. (Triozzi, Heather) |
| Jul 8, 2019 | 17 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) |
| Jul 1, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 7/1/2019. Local Counsel present for Plaintiffs: J. Blumenfeld. Local Counsel present for Defendant: K. Keller. The Court will enter the scheduling order as discussed. (Court Reporter Heather Triozzi.) (nms) |
| Jul 1, 2019 | 15 | Scheduling Order (8) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/1/2019. Amended Pleadings due by 8/1/2019. Fact Discovery completed by 12/10/2019. Joint Claim Construction Brief due by 10/11/2019. A Markman Hearing is set for 10/25/2019, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 10/2/2020, at 8:30 AM in Courtroom 6A. A 3-day Bench Trial is set for 10/13/2020, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 7/1/2019. (nms) |
| Jun 28, 2019 | 14 | Proposed Order (8) Docket Text: PROPOSED Scheduling Order, by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A.. (Tigan, Jeremy) Modified on 6/28/2019 (nms). |
| May 16, 2019 | N/A | SO ORDERED (0) |
| May 16, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Leora Ben-Ami, Thomas Fleming, Justin Bova, Ashley Ross, Christopher T. Jagoe, and Noah Frank - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| May 9, 2019 | 12 | Answer to Counterclaim (9) Docket Text: ANSWER to [9] Answer to Complaint, and Counterclaims, Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A..(Tigan, Jeremy) Modified on 5/13/2019 (nms). |
| May 1, 2019 | 11 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 7/1/2019, at 11:30 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 5/1/2019. (nms) |
| Apr 18, 2019 | 9 | Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Apr 18, 2019 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Apr 12, 2019 | N/A | SO ORDERED (0) |
| Apr 12, 2019 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to April 18, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Mar 18, 2019 | N/A | SO ORDERED (0) |
| Mar 18, 2019 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to Complaint to April 12, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Feb 27, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (bkb) |
| Feb 27, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Galderma S.A., Galderma Laboratories, L.P., Nestle Skin Health S.A.. Teva Pharmaceuticals USA, Inc. served on 2/27/2019, answer due 3/20/2019. (Tigan, Jeremy) |
| Feb 21, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 2/21/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc) |
| Feb 19, 2019 | 1 | Exhibit A (27) |
| Feb 19, 2019 | 1 | Civil Cover Sheet (1) |
| Feb 19, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) |
| Feb 19, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 3/13/34. (rwc) |
| Feb 19, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,206,939 B2. (rwc) |
| Feb 19, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma General, L.L.C., Corporate Parent Galderma Limited, L.L.C., Corporate Parent Nestle Skin Health U.S., Inc. for Galderma Laboratories, L.P.; Corporate Parent Galderma Pharma S.A. for Galderma S.A. filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A. (rwc) |
| Feb 19, 2019 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2573986.) - filed by Galderma S.A., Galderma Laboratories, L.P., Nestle Skin Health S.A. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(rwc) |
| Feb 19, 2019 | 1 | Complaint* (1) |
